Tacitus Therapeutics Launches in Collaboration with Mount Sinai to Develop Stem Cell Therapies for Life-Threatening Diseases
Tacitus Therapeutics exclusively licenses technology for expansion, differentiation and engineering of hematopoietic stem cells for use in therapeutic applications Tacitus Therapeutics, a clinical-stage company, has launched in collaboration with the Mount Sinai Health System to develop stem cell therapies initially targeting blood …
Life Science Development and the Future of Medicine: The Mount Sinai Perspective
Mount Sinai Innovation Partners (MSIP) participated in several conferences and events to wrap up 2019, gathering thought leaders and industry experts to discuss best practices on building a strong life science ecosystem for the purpose of helping patient populations. These events included …
Nines Debuts Mission to Redefine Radiology, Delivering Next-level Patient Care
Nines’ unique approach to teleradiology reimagines radiology together with engineering and data science prowess to bring a new level of patient care Nines debuts as the first-of-its-kind teleradiology practice that combines top quality radiologists and world-class engineering to deliver high-quality diagnostics and …
Human Immune Monitoring Center at Mount Sinai to Analyze the Effectiveness of a Novel Cancer Therapy Drug
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi. While …
Onegevity Health Acquires Global Licensing Rights to Mount Sinai’s Lab100
Clinic and research lab offers patients access to comprehensive health assessment, expands clinical understanding of disease prevention and provides wealth of health outcomes data Onegevity Health, LLC, a New York City-based health technology company focused on biometric data, artificial intelligence and personalized …
Mount Sinai Innovation Partners Announces Inventor of the Year and Deal of the Year 2019
At the Innovation Awards Ceremony on October 14, Mount Sinai Innovation Partners (MSIP) presented the award for Inventor of the Year to Edward Schuchman, PhD, and Calogera (Lilla) Simonaro, PhD, and Deal of the Year to the RenalytixAI team at Mount Sinai: …
A Framework for the Pursuit of Innovation
Written by Sharlin Bird, Strategic Relations Specialist at KLAS Research In conversation with Erik Lium, PhD, Executive Vice President, Mount Sinai Innovation Partners (MSIP) Driving innovation in healthcare is a challenging endeavor. It is a market full of dynamic customers, a variety …
MSIP and NYEE Launch iLABS, Featuring the Latest Technology in Ophthalmic Care
The inaugural iLABS event took place on September 19, showcasing the latest technologies in ophthalmology from Mount Sinai Health System innovators. Hosted by the Mount Sinai Department of Ophthalmology, the New York Eye and Ear (NYEE) Infirmary Program for Innovation and Technology, …
Sinai BioDesign Hosts FDA Representative to Discuss Medical Device Submissions
Sinai BioDesign, an organization of the Icahn School of Medicine at Mount Sinai focused on the development of biomedical technologies, hosted U.S. Food and Drug Administration (FDA) representative Joshua Chetta on October 1 to discuss the regulations and requirements for device submission …